Individual investors buy into vaccination bond issue

Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs of a campaign and they will be repaid as governments fund the programs. This is the first time that individual investors have bought into a vaccination bond program and it could prove a model for future fundraising efforts in other countries.

In this case, Japanese investors paid as little as $1,270 to buy into the issue from the International Finance Facility for Immunization. In 2006 the first IFFim bond raised $1 billion from institutions in London and underwritten by a group of countries including the UK.

- read the report from the Financial Times 

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.